Utilizing GLP Medications for Cost Savings
In the current landscape of diabetes management, one question frequently arises: Do GLP (glucagon-like peptide) medications genuinely save employers money? The clear answer is yes, especially when these medications are incorporated into a well-rounded diabetes management plan. Such an approach not only focuses on medication but also incorporates vital behavior changes necessary for effective diabetes control.
Abacus Health Solutions' Approach to Diabetes Care
Abacus Health Solutions has been leading the charge in diabetes care innovation, particularly through their Diabetes Care Rewards Program. This pioneering program incentivizes patients to engage in long-term health practices, effectively lowering diabetes care costs for both employees and employers. Their study indicates a direct correlation between the utilization of GLP medications and a decrease in hospital admissions, a primary driver of diabetes-related expenses. This not only enhances health outcomes but also significantly alleviates financial burdens on employers.
The Demand for GLP Medications
As diabetes is rapidly becoming the fastest-growing chronic disease worldwide, the demand for GLP medications such as Ozempic and Mounjaro is surging. These newer medications are backed by extensive research underscoring their clinical benefits, including improved blood glucose control, weight management, and lowered cardiovascular risks. However, the high costs associated with these medications—often exceeding $1,000 monthly—pose substantial challenges for employers aiming to manage healthcare costs.
Impact of GLP on Hospital Admissions
Research conducted by Abacus on a municipal client using their Diabetes Care Program for three years demonstrates promising results. With over 70,000 lives covered under their health plans, including more than 4,000 members with diabetes, the analysis reveals that those utilizing GLP medications experienced 29% fewer hospital admissions compared to the broader diabetes population. Even more strikingly, participants combining GLP use with active engagement in the Abacus program saw a 40% reduction in hospital admissions. This highlights the powerful synergy of medication and comprehensive care strategies in reducing health risks associated with diabetes.
Engaging High-Risk Individuals
Abacus’s strategic advantage lies in its ability to engage high-risk diabetes patients. Evidence suggests that individuals with a history of cardiovascular disease, among other chronic conditions, are particularly susceptible to hospital admissions. Remarkably, the data shows that even these higher-risk participants exhibit lower hospitalization rates when they actively participate in the Abacus Program, demonstrating the program's effectiveness in mitigating health risks.
Comprehensive Diabetes Management Strategies
It is crucial to recognize that effective diabetes management extends beyond merely prescribing GLP medications. Abacus ensures that participants on these medications maintain healthy behaviors critical for diabetes management. Many individuals face gaps in essential preventive care, but those enrolled in the Abacus Program frequently report increased doctor visits, reduced gaps in preventive care, consistent medication adherence, and a decrease in hospitalizations.
About Abacus Health Solutions
Abacus Health Solutions is a leader in reducing chronic condition costs while enhancing health outcomes, particularly for complex cases. Armed with data-driven and AI-supported solutions, Abacus empowers organizations to better serve individuals managing diabetes and related conditions. Established by esteemed medical professionals and experts in behavioral science, Abacus engages patients via their Good Health Gateway online platform. By rewarding optimal health behaviors that align with clinical guidelines, they significantly reduce healthcare costs and foster increased well-being for both individuals and organizations.
Contact Information:
Sean Follick
Abacus Health Solutions, LLC.
Frequently Asked Questions
What are GLP medications?
GLP medications are a class of drugs used to treat Type 2 diabetes, helping to regulate blood sugar levels and promote weight loss.
How do GLP medications save employers money?
By reducing hospital admissions and overall healthcare costs through effective diabetes management.
What is the role of Abacus Health Solutions?
Abacus provides innovative programs and solutions that incentivize healthier behaviors in individuals managing diabetes.
What are the benefits of the Diabetes Care Rewards Program?
This program encourages long-term health practices, leading to lower healthcare costs and improved health outcomes.
How can high-risk individuals benefit from this program?
The program engages high-risk individuals, providing them with the tools and support needed to manage their diabetes effectively and reduce their risk of hospitalization.
